Massive study tracks 1,000 people to unlock secrets of eczema remission

NCT ID NCT04240522

Recruiting now Knowledge-focused Sponsor: University of Zurich Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This long-term study follows 1,000 people with eczema and related allergies, plus healthy volunteers, to see what factors help the disease go into remission. Researchers will collect medical and lifestyle data to find patterns and possible biomarkers. The goal is to better understand why some people improve and others don't, paving the way for more personalized care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could identify factors and biomarkers that predict remission, pointing toward better personalized treatments for eczema and related allergies.
What could go wrong: This is an observational study, not a treatment trial. It collects data over time and cannot directly test whether any intervention works. Results may take years and may not lead to immediate therapies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALLERGIC ASTHMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

allergic asthma allergic rhinitis asthma atopic eczema dermatitis Eczema food allergy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ASTHMA ATOPIC DERMATITIS ATOPIC DERMATITIS AND RELATED CONDITIONS

Contacts and locations

Locations

Allergy Unit, Dept. of Dermatology, Unviersity Hosptial of Zurich
RECRUITING

Zurich, Canton of Zurich, 8091, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.